
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+16
We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERTTM platform, which is based on our Flow Electroporation technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATxTM, STxTM, GTxTM and VLx TM; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a robust...
Vaccine development,protein production,transfection,cell therapy,gene therapy,cancer,immunotherapy,electroporation,myexpertplatform,tcell,nkcell,bispecifics,gene editing,cancer research,immuno-oncology,stem cell,carma,cell engineering,biotechnology,life sciences,and innovation
Maxcyte, inc operates in the Biotechnology industry.
Maxcyte, inc's revenue is 11m - 100m
Maxcyte, inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.